Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Mater Sci Mater Med ; 19(12): 3585-91, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18629617

ABSTRACT

Titanium nitride (TiN) coating has been proposed as an adjunctive surface treatment aimed to increase the physico-mechanical and aesthetic properties of dental implants. In this study we investigated the biological response of primary human bone marrow stromal cells (BMSC) to TiN-coated sandblasted (TiN-SB) compared to uncoated sandblasted (SB) surfaces. SB and TiN-SB disks were qualitatively and quantitatively analyzed by atomic force microscopy. BMSC were obtained from healthy donors and their adhesion and proliferation on the titanium disks were evaluated by scanning electron microscopy and viability assay. The osteoblastic differentiation, in terms of alkaline phosphatase activity, osteocalcin synthesis, and extracellular mineralization, was assessed by specific immunoenzymatic or spectrophotometric assays. No difference (P > 0.05) between TiN-SB and SB disks was found in terms of any of the investigated parameters. TiN-coating showed to maintain the topographical characteristics of sandblasted titanium surfaces and their biological affinity toward bone precursors.


Subject(s)
Coated Materials, Biocompatible/chemistry , Dental Alloys/chemistry , Dental Implants , Stromal Cells/cytology , Titanium/chemistry , Adult , Alkaline Phosphatase/analysis , Bone Marrow Cells/cytology , Calcification, Physiologic , Cell Adhesion , Cell Proliferation , Cells, Cultured , Extracellular Matrix/physiology , Female , Humans , Male , Osteoblasts/cytology , Osteoblasts/ultrastructure , Osteocalcin/biosynthesis , Stromal Cells/ultrastructure , Surface Properties , Time Factors
2.
J Periodontol ; 78(11): 2190-6, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17970687

ABSTRACT

BACKGROUND: In vitro investigations suggest that enamel matrix derivative (EMD) may affect the biologic response of periodontal-related cells, including osteoblasts and their precursors, the bone marrow stromal cells (BMSCs), which could play a crucial role in the regenerative process. In this study, we investigated the effects of EMD on human BMSCs. METHODS: Primary cultures of BMSCs were obtained from bone marrow samples of healthy donors. Cell proliferation and osteogenic marker expression in response to serial dilutions of EMD (12.5, 25, and 50 microg/ml) were assessed. Cell growth was measured by 3H-thymidine incorporation and type I collagen synthesis by immunoblotting. Alkaline phosphatase (AP)-specific activity in the early phase (7 days), in vitro mineralization by von Kossa staining and calcium quantification, and osteocalcin levels at prolonged times (3 weeks) also were evaluated. RESULTS: EMD stimulated BMSC growth in a dose-dependent manner. When EMD 50 microg/ml was followed over time, the highest proliferative effect was evident at 24 hours (3.4-fold of the control). Type I collagen level was significantly lower than the control after a 7-day incubation with EMD 50 microg/ml. AP activity was reduced in a dose-dependent manner down to 55% of the control. Also, the extracellular matrix mineralization decreased in EMD-treated cells with respect to the control, whereas only a slight, not significant, decrease in osteocalcin levels was found. CONCLUSIONS: EMD significantly increased BMSC growth and simultaneously decreased their osteogenic differentiation. The clinical efficacy of EMD in regenerating periodontal tissues can be attributed, in part, to the biologic effects exerted on the bone marrow stromal component of resident cells.


Subject(s)
Bone Marrow Cells/cytology , Dental Enamel Proteins/pharmacology , Dental Materials/pharmacology , Adult , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Collagen/analysis , Collagen/biosynthesis , Female , Humans , Male , Osteocalcin/analysis , Stromal Cells/drug effects
3.
Eur J Biochem ; 269(22): 5689-99, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12423369

ABSTRACT

This paper describes the cloning of the genes coding for each component of the complex of toluene/o-xylene monooxygenase from Pseudomonas stutzeri OX1, their expression, purification and characterization. Moreover, the reconstitution of the active complex from the recombinant subunits has been obtained, and the functional role of each component in the electron transfer from the electron donor to molecular oxygen has been determined. The coexpression of subunits B, E and A leads to the formation of a subcomplex, named H, with a quaternary structure (BEA)2, endowed with hydroxylase activity. Tomo F component is an NADH oxidoreductase. The purified enzyme contains about 1 mol of FAD, 2 mol of iron, and 2 mol of acid labile sulfide per mol of protein, as expected for the presence of one [2Fe-2S] cluster, and exhibits a typical flavodoxin absorption spectrum. Interestingly, the sequence of the protein does not correspond to that previously predicted on the basis of DNA sequence. We have shown that this depends on minor errors in the gene sequence that we have corrected. C component is a Rieske-type ferredoxin, whose iron and acid labile sulfide content is in agreement with the presence of one [2Fe-2S] cluster. The cluster is very sensitive to oxygen damage. Mixtures of the subcomplex H and of the subunits F, C and D are able to oxidize p-cresol into 4-methylcathecol, thus demonstrating the full functionality of the recombinant subunits as purified. Finally, experimental evidence is reported which strongly support a model for the electron transfer. Subunit F is the first member of an electron transport chain which transfers electrons from NADH to C, which tunnels them to H subcomplex, and eventually to molecular oxygen.


Subject(s)
Oxygenases/chemistry , Oxygenases/isolation & purification , Biochemical Phenomena , Biochemistry , Chromatography, Gel , Dithionite/chemistry , Electron Transport , Electrons , Electrophoresis, Polyacrylamide Gel , Escherichia coli/metabolism , Genetic Vectors , Iron/metabolism , Mass Spectrometry , NAD/chemistry , Plasmids/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Sulfides/chemistry
4.
Blood ; 99(6): 2017-22, 2002 Mar 15.
Article in English | MEDLINE | ID: mdl-11877274

ABSTRACT

Vitamin A is a pivotal biochemical factor required for normal proliferation and differentiation as well as for specialized functions, such as vision. The dietary intake of 1500 IU/day is recommended in the first year of life. Here, we report the case of an infant who had been given 62 000 IU/day for 80 days. The infant showed several clinical signs of retinol intoxication, including severe anemia and thrombocytopenia. Bone marrow showed a remarkably reduced number of erythroid and megakaryocytic cells. The interruption of vitamin A treatment was immediately followed by clinical and biochemical recovery. To clarify whether the effects of retinol are due to a direct action on bone marrow cell proliferation, we investigated the activity of retinol (both the drug and the pure molecule) on the growth of K-562, a multipotent hematopoietic cell line, and on bone marrow mesenchymal stem cells. We observed that vitamin A strongly inhibited the proliferation of the cells at concentrations similar to those reached in vivo. Subsequent biochemical analyses of the cell cycle suggested that the effect was mediated by the up-regulation of cyclin-dependent kinase inhibitors, p21(Cip1) and p27(Kip1). These are the first findings to demonstrate that infant hypervitaminosis A causes a severe anemia and thrombocytopenia and that this is probably due to the direct effect of the molecule on the growth of all bone marrow cellular components. Our data also suggest potential bone marrow functional alterations after excessive vitamin A intake because of emerging social habits.


Subject(s)
Anemia/etiology , Hypervitaminosis A/complications , Thrombocytopenia/etiology , Anemia/pathology , Bone Marrow Cells/drug effects , Cell Cycle Proteins/biosynthesis , Cell Cycle Proteins/drug effects , Cell Division/drug effects , Child , Child, Preschool , Cyclin-Dependent Kinase Inhibitor p21 , Cyclin-Dependent Kinase Inhibitor p27 , Cyclins/biosynthesis , Cyclins/drug effects , Erythroid Precursor Cells/drug effects , Humans , Hypervitaminosis A/chemically induced , Hypervitaminosis A/pathology , Infant , K562 Cells/drug effects , Male , Mesoderm/cytology , Mesoderm/drug effects , Thrombocytopenia/pathology , Tumor Suppressor Proteins/biosynthesis , Tumor Suppressor Proteins/drug effects , Up-Regulation/drug effects , Vitamin A/pharmacology , Vitamin A/physiology , Vitamin A/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...